Mersana Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	56.39	107.75	174.56	128.89	177.95	255.09
Short-Term Investments	-	26.87	34.52	151.83	-	-
Cash & Short-Term Investments	56.39	134.62	209.08	280.71	177.95	255.09
Cash Growth	-63.66%	-35.61%	-25.52%	57.75%	-30.24%	155.63%
Accounts Receivable	0.17	-	-	30	-	-
Other Current Assets	3.43	2.28	4.97	8.51	10.95	3.49
Total Current Assets	59.99	136.9	214.06	319.22	188.9	258.58
Net Property, Plant & Equipment	2.2	6.78	11.53	14.46	14.86	12.67
Other Long-Term Assets	0.5	0.98	0.48	0.66	2.36	2.15
Total Assets	62.69	144.66	226.06	334.34	206.11	273.4
Accounts Payable	2.39	4.33	7.32	13.95	12.32	8.34
Accrued Expenses	14.81	18.96	21.9	43.18	28.72	16.15
Short-Term Debt	-	12.5	2.08	-	-	-
Current Portion of Leases	2.29	3.86	3.25	2.8	2.3	1.44
Unearned Revenue	23.77	22.17	28.15	30.61	3.94	3.99
Other Current Liabilities	-	0.64	0.94	0.99	0.24	0.09
Total Current Liabilities	43.27	62.46	63.64	91.53	47.52	30
Long-Term Debt	-	10.95	23.15	24.93	24.63	4.98
Long-Term Leases	-	1.29	5.15	8.58	11.25	10.16
Other Long-Term Liabilities	78.95	79.47	97.22	117.25	0.97	0.17
Total Long-Term Liabilities	78.95	91.71	125.52	150.75	36.85	15.31
Total Liabilities	122.22	154.17	189.16	242.28	84.37	45.31
Common Stock	-	-	0	0.01	0.01	0
Additional Paid-in Capital	891.98	886.03	863.24	746.89	572.21	508.5
Accumulated Other Comprehensive Income	-	0.01	0.01	-0.15	-	-
Retained Earnings	-951.52	-895.55	-826.36	-654.69	-450.48	-280.42
Shareholders' Equity	-59.54	-9.51	36.89	92.06	121.74	228.08
Total Liabilities & Equity	62.69	144.66	226.06	334.34	206.11	273.4
Total Debt	2.29	28.6	33.63	36.3	38.18	16.57
Net Cash (Debt)	54.1	106.02	175.45	244.41	139.77	238.52
Net Cash Growth	-48.98%	-39.57%	-28.21%	74.87%	-41.40%	159.19%
Net Cash Per Share	10.87	21.63	37.78	65.24	49.51	96.98
Book Value	-59.54	-9.51	36.89	92.06	121.74	228.08
Book Value Per Share	-11.97	-1.94	7.94	24.57	43.12	92.74
Tangible Book Value	-59.54	-9.51	36.89	92.06	121.74	228.08
Tangible Book Value Per Share	-11.97	-1.94	7.94	24.57	43.12	92.74

SEC Filings: 10-K · 10-Q